Literature DB >> 2536215

Acute secondary effects in the esophagus in patients undergoing radiotherapy for carcinoma of the lung.

F Mascarenhas1, M E Silvestre, M Sá da Costa, N Grima, C Campos, P Chaves.   

Abstract

The incidence and nature of acute secondary irradiation esophagitis was studied in a series of 38 patients undergoing 60Co teletherapy for carcinoma of the lung. Thirty-four patients were male and four female, with ages ranging from 38 to 78 years. The mediastinum being irradiated in the process, all the patients underwent endoscopy for signs of esophagitis and/or gastritis after a dose of 30-40 Gy was delivered to the esophagus. Eighteen patients complained of dysphagia, but only in 12 of them did endoscopy show esophagitis. Of the remaining patients without complaints five had endoscopic signs of esophagitis. Gastritis was found in 18 cases and confirmed histologically in 14. In 17 cases, esophagitis and/or gastritis were confirmed histologically. It is believed that there is a fairly close correlation among clinical, endoscopic, and histological findings to support the claim that esophagitis in these patients is radiation induced. However, the cause of gastritis is not well understood. Data in the literature suggest that nonsteroid anti-inflammatory agents can act as prophylactic means of preventing radiation esophagitis.

Entities:  

Mesh:

Year:  1989        PMID: 2536215     DOI: 10.1097/00000421-198902000-00008

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  6 in total

1.  Prevention of radiation esophagitis by polaprezinc (zinc L-carnosine) in patients with non-small cell lung cancer who received chemoradiotherapy.

Authors:  Komei Yanase; Norihiko Funaguchi; Hirotoshi Iihara; Maya Yamada; Daizo Kaito; Junki Endo; Fumitaka Ito; Yasushi Ohno; Hidekazu Tanaka; Yoshinori Itoh; Shinya Minatoguchi
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Pharmacological and dietary prophylaxis and treatment of acute actinic esophagitis during mediastinal radiotherapy.

Authors:  F S Sasso; G Sasso; H R Marsiglia; G de Palma; C Schiavone; A Barone; A Polo; R Orecchia
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

3.  Morphology and pathology of radiation-induced esophagitis. Double-blind study of naproxen vs placebo for prevention of radiation injury.

Authors:  E E Soffer; F Mitros; J F Doornbos; J Friedland; J Launspach; R W Summers
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

4.  Development and evaluation of screening dysphagia tools for observational studies and routine care in cancer patients.

Authors:  Michael Borean; Kishan Shani; M Catherine Brown; Judy Chen; Mindy Liang; Joel Karkada; Simranjit Kooner; Mark K Doherty; Grainne M O'Kane; Raymond Jang; Elena Elimova; Rebecca K Wong; Gail E Darling; Wei Xu; Doris Howell; Geoffrey Liu
Journal:  Health Sci Rep       Date:  2018-05-21

5.  Scintigraphic evaluation of oesophageal transit during radiotherapy to the mediastinum.

Authors:  Giuseppe Sasso; Pierfrancesco Rambaldi; Francesco S Sasso; Vincenzo Cuccurullo; Paola Murino; Paolo Puntieri; Hugo R Marsiglia; Luigi Mansi
Journal:  BMC Gastroenterol       Date:  2008-11-05       Impact factor: 3.067

6.  Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy.

Authors:  Shuanghu Tiger Yuan; Richard K J Brown; Lujun Zhao; Randall K ten Haken; Milton Gross; Kemp B Cease; Matt Schipper; Paul Stanton; Jinming Yu; Feng-Ming Spring Kong
Journal:  Radiat Oncol       Date:  2014-01-27       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.